» Articles » PMID: 35887394

Analysis of Binding Determinants for Different Classes of Competitive and Noncompetitive Inhibitors of Glycine Transporters

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jul 27
PMID 35887394
Authors
Affiliations
Soon will be listed here.
Abstract

Glycine transporters are interesting therapeutic targets as they play significant roles in glycinergic and glutamatergic systems. The search for new selective inhibitors of particular types of glycine transporters (GlyT-1 and GlyT-2) with beneficial kinetics is hampered by limited knowledge about the spatial structure of these proteins. In this study, a pool of homology models of GlyT-1 and GlyT-2 in different conformational states was constructed using the crystal structures of related transporters from the SLC6 family and the recently revealed structure of GlyT-1 in the inward-open state, in order to investigate their binding sites. The binding mode of the known GlyT-1 and GlyT-2 inhibitors was determined using molecular docking studies, molecular dynamics simulations, and MM-GBSA free energy calculations. The results of this study indicate that two amino acids, Gly373 and Leu476 in GlyT-1 and the corresponding Ser479 and Thr582 in GlyT-2, are mainly responsible for the selective binding of ligands within the S1 site. Apart from these, one pocket of the S2 site, which lies between TM3 and TM10, may also be important. Moreover, selective binding of noncompetitive GlyT-1 inhibitors in the intracellular release pathway is affected by hydrophobic interactions with Ile399, Met382, and Leu158. These results can be useful in the rational design of new glycine transporter inhibitors with desired selectivity and properties in the future.

Citing Articles

Glycine Transporter 1 Inhibitors: Predictions on Their Possible Mechanisms in the Development of Opioid Analgesic Tolerance.

Galambos A, Papp Z, Boldizsar I, Zador F, Koles L, Harsing Jr L Biomedicines. 2024; 12(2).

PMID: 38398023 PMC: 10886540. DOI: 10.3390/biomedicines12020421.


Cross-Linking and Functional Analyses for Dimerization of a Cysteine Mutant of Glycine Transporter 1.

Wang J, Liu H, Zhang Y Int J Mol Sci. 2022; 23(24).

PMID: 36555800 PMC: 9781295. DOI: 10.3390/ijms232416157.


Analysis of Different Binding Modes for Tiagabine within the GAT-1 Transporter.

Latka K, Bajda M Biomolecules. 2022; 12(11).

PMID: 36359013 PMC: 9687605. DOI: 10.3390/biom12111663.

References
1.
Sheffler D, Nedelcovych M, Williams R, Turner S, Duerk B, Robbins M . Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres. Bioorg Med Chem Lett. 2014; 24(4):1062-6. PMC: 3951244. DOI: 10.1016/j.bmcl.2014.01.011. View

2.
Harsing Jr L, Juranyi Z, Gacsalyi I, Tapolcsanyi P, Czompa A, Matyus P . Glycine transporter type-1 and its inhibitors. Curr Med Chem. 2006; 13(9):1017-44. DOI: 10.2174/092986706776360932. View

3.
Carland J, Thomas M, Mostyn S, Subramanian N, OMara M, Ryan R . Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2. ACS Chem Neurosci. 2017; 9(3):603-614. DOI: 10.1021/acschemneuro.7b00407. View

4.
Legendre P . The glycinergic inhibitory synapse. Cell Mol Life Sci. 2001; 58(5-6):760-93. PMC: 11337367. DOI: 10.1007/pl00000899. View

5.
Song I, Cho S, Nedeljkovic S, Lee S, Lee C, Kim J . Role of VVZ-149, a Novel Analgesic Molecule, in the Affective Component of Pain: Results from an Exploratory Proof-of-Concept Study of Postoperative Pain following Laparoscopic and Robotic-Laparoscopic Gastrectomy. Pain Med. 2021; 22(9):2037-2049. DOI: 10.1093/pm/pnab066. View